A California Assembly committee has unanimously approved a revised bill to create a state workgroup that would be tasked with exploring a regulatory framework to provide therapeutic access to psychedelics like psilocybin and ibogaine.
The Assembly Health Committee passed the legislation from Assemblymember Marie Waldron (R) in a 11-0 vote on Tuesday. It now heads to the Appropriations Committee before potentially moving to the floor.
If the legislature were to enact a regulatory framework as recommended by the workgroup, which would be situated under the California Health and Human Services Agency (CalHHS), the bill would also allow health practitioners to lawfully administer psychedelics in a therapeutic setting.
The version of the legislation that is moving forward has been amended from what Waldron initially introduced last year, which focused exclusively on psychedelics-assisted therapy for military veterans. But the revision comes as the sponsor works with Sen. Scott Wiener (D) on separate legislation to establish a broader therapeutic access model for psychedelics in California.
“California is experiencing a severe mental health crisis with rising rates of anxiety, depression, substance use, post-traumatic stress disorder, suicide and other debilitating conditions,” Waldron said at Tuesday’s hearing. “My bill, AB 941, proposes a solution to this crisis through the exploration of the therapeutic possibilities of psychedelic-assisted therapy. We need the data, the research and the recommendations of experts in this promising field of therapeutics.”
“These therapies have the potential to save countless lives,” she said.
However, the sponsor emphasized that this is a “true study bill” and that “no one will be treated with psychedelics under the bill.” That said, while the measure wouldn’t automatically allow therapeutic access to psychedelics, it does say it would become lawful if the legislature adopts a regulatory framework as recommended by the workgroup.
Accordingly, psychedelic-assisted therapy is defined as “supervised, lawful medical use of a controlled substance for treatment, including, but not limited to, group counseling and community-based healing, under the care of, administration by, and treatment of a licensed professional in a clinical setting.”
Wiener also testified at Tuesday’s hearing, stating that he’s in “full support” of the incremental reform bill and then previewing plans to introduce additional legislation in the next few weeks to “legalize and create a structure for psychedelic-assisted therapy in line with the governor’s veto message of our psychedelic decriminalization bill last year.”
Wiener has been pushing for psychedelics reform over the past few legislative cycles, with his bill to legalize certain entheogenic substances passing the legislature last year, only to be vetoed by Gov. Gavin Newsom (D). In his veto message, the governor encouraged lawmakers to send an alternative proposal to his desk that focuses on therapeutic access—and that’s what Wiener and Waldron are aiming to do with a measure that is still forthcoming.
In the meantime, Waldron’s newly revised measure is designed to be more limited than what the bipartisan duo plan to soon introduce.
It would require the CalHHS to establish a workgroup “to study and make recommendations on the establishment of a framework governing psychedelic-assisted therapy,” the legislative summary says.
“The bill would require that workgroup to send a report to the Legislature containing those recommendations on or before January 1, 2026,” it says. And if the legislature does enact a framework for psychedelics-assisted therapy, it would “authorize a facilitator in a licensed facility to administer specified controlled substances to combat veterans.”
Wiener told Marijuana Moment last week that his partner on the broader push informed him that her revised legislation is being moved “as a backup to our bill, not in lieu” of it. He said the plan is to introduce their separate bipartisan measure later this month or early February.
The state is at an “inflection point” on psychedelics reform, the senator said at an event last month, adding that he understood the governor’s primary contention with his last bill was with provisions to legalize low-level possession of certain psychedelics.
—
Marijuana Moment is tracking more than 900 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Meanwhile, a campaign behind a prospective California ballot initiative to legalize psychedelics filed a final revised measure with state officials last month, making a handful of changes to the proposal following a public comment period that ended late in November.
The California Legislative Analyst’s Office (LAO) has since released its review of that proposal, outlining not only the plan’s policy implications but also its potential fiscal impacts on the state—which the report calls “various” and “uncertain.”
While adults would be allowed to legally grow, possess and use substances like psilocybin, LSD, MDMA, DMT, ibogaine and mescaline under the measure, they would need physician recommendations to purchase the psychedelics at regulated stores.
A separate ballot proposal, meanwhile, would legalize psilocybin, including adult-use sales. That measure, backed by the group Decriminalize California, recently got approval from state officials to begin collecting signatures. Activists have tried twice to put the reform on the ballot in prior cycles, but they’ve come up short due in large part to signature gathering complications during the pandemic.
A third California campaign withdrew its proposed ballot initiative to create a $5 billion state agency tasked with funding and promoting psychedelics research in November, citing polling that advocates say led them to reevaluate whether to put resources into the effort.
Some California municipalities, meanwhile, are pushing forward with reform on the local level. The city of Eureka, for example, adopted a resolution in October to decriminalize psychedelic plants and fungi and make enforcement of laws against personal use, cultivation and possession a low priority for police. It’s at least the fifth local jurisdiction in the state to embrace the policy change. Others include San Francisco, Oakland, Santa Cruz and Arcata.
Delaware House Committee Approves Bill To Significantly Expand Medical Marijuana Program Ahead Of Adult-Use Sales Launch
Image courtesy of Kristie Gianopulos.
Read the full article here
